Strategy
Our approach to Growth Equity investments
We are an engaged investor in, and a partner to, life science companies at the leading edge of innovation.
We invest in companies harnessing the transformative power of biology and technology. In particular, we focus on investments in clinical diagnostics, industrial biotechnology, biologics supply chain, and healthcare IT.
We leverage our deep scientific knowledge, operational expertise and global network for the benefit of our portfolio companies.
We have evergreen capabilities that allow us to have a longer-term horizon, and be a true partner dedicated to enabling our portfolio companies to fulfil their potential.
